Skip to main content

What the FDA labels say about taking them together

Estradiol/norethindrone and fosamprenavir

Fosamprenavir's FDA label of September 15, 2023 names estradiol/norethindrone in its drug interactions section; the estradiol/norethindrone labels PlainMeds reads (2) do not name fosamprenavir. The fosamprenavir label: “Oral contraceptives: Ethinyl estradiol/norethindrone Fosamprenavir: ↓ Amprenavir ↓ Ethinyl estradiol Alternative methods of non-hormonal contraception are recommended.”

Check it at the source: the estradiol/norethindrone FDA label on DailyMed (effective January 16, 2025, Amneal Pharmaceuticals NY LLC); the fosamprenavir FDA label on DailyMed (effective September 15, 2023, Mylan Pharmaceuticals Inc.).

What does the estradiol/norethindrone label say about fosamprenavir?

Estradiol/norethindrone's label (effective January 16, 2025) and its 1 other brand-application label do not name fosamprenavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LOPREEZA), Amneal Pharmaceuticals NY LLC, effective January 16, 2025 (SPL set 966ac064-9eb7-4d15-b271-a7880ed1e79a), via openFDA; the full label on DailyMed

What does the fosamprenavir label say about estradiol/norethindrone?

Fosamprenavir label, drug interactions

Oral contraceptives: Ethinyl estradiol/norethindrone Fosamprenavir: ↓ Amprenavir ↓ Ethinyl estradiol Alternative methods of non-hormonal contraception are recommended.

Source: FDA drug label (Fosamprenavir Calcium), Mylan Pharmaceuticals Inc., effective September 15, 2023 (SPL set 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

7Estradiol/norethindrone generic labelers
2Fosamprenavir generic labelers
Estradiol/norethindroneFosamprenavir
Labeled forMenopause symptoms, OsteoporosisHIV
Boxed warningYesNo
Pharmacy cost (NADAC)$0.802 per tablet 0.5-0.1 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?